TP53 and type 2 diabetes mellitus: Consistently, individuals with T2D typically display an elevated senescent cell burden in AT, as demonstrated by the high expression levels of SA-β-gal, p53, p21, and pro-inflammatory SASP components (e.g., IL-1α, IL-1β, IL-6, and TNF-α) [94].